Detalhe da pesquisa
1.
Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists.
Bioorg Med Chem Lett
; 25(19): 4158-63, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26299349
2.
Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity Disorder.
J Exp Pharmacol
; 16: 13-24, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38249320
3.
Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity.
Synapse
; 66(5): 435-44, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22213370
4.
Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
Synapse
; 66(6): 522-32, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22298359
5.
Muscarinic mechanisms in psychotic disorders.
Handb Exp Pharmacol
; (213): 233-65, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23027418
6.
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.
Pharmacol Rev
; 60(3): 358-403, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18922967
7.
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.
J Clin Invest
; 116(3): 825-32, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16498501
8.
Case history: the discovery of fluoxetine hydrochloride (Prozac).
Nat Rev Drug Discov
; 4(9): 764-74, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16121130
9.
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
Neuropharmacology
; 50(6): 755-60, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16427661
10.
Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles.
Circulation
; 109(25): 3202-7, 2004 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-15184278
11.
The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.
Curr Pharm Des
; 11(12): 1475-93, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15892657
12.
M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.
FASEB J
; 18(12): 1410-2, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15231726
13.
Amantadine for weight gain associated with olanzapine treatment.
Eur Neuropsychopharmacol
; 15(1): 13-21, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15572269
14.
Antipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primates.
PLoS One
; 10(4): e0122722, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880220
15.
Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.
Eur J Pharmacol
; 764: 30-37, 2015 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26101069
16.
Muscarinic receptors as a target for drugs treating schizophrenia.
Curr Drug Targets CNS Neurol Disord
; 1(2): 163-81, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12769625
17.
Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.
Neuropsychopharmacology
; 28(9): 1685-93, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12784100
18.
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.
Neuropsychopharmacology
; 28(6): 1168-75, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12700711
19.
R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
Neuropsychopharmacology
; 27(6): 949-59, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12464452
20.
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
Neuropsychopharmacology
; 27(5): 699-711, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12431845